Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 689-702

  Orza, Anamaria ^a,b   Soriţǎu, Olga ^c   Tomuleasa, Ciprian ^c,d   Olenic, Liliana ^e   Florea, Adrian ^d   Pana, Ovidiu ^e   Bratu, Ioan ^e   Pall, Emoke ^f   Florian, Stefan ^c   Casciano, Dan ^b   Biris, Alexandru S ^b  

^a BABE BOLYAI UNIVERSITY   (Romania)

^b UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^c THE ONCOLOGY INSTITUTE PROF DR ION CHIRICUTA   (Romania)

^d IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^e NATIONAL INSTITUTE FOR RESEARCH AND DEVELOPMENT OF ISOTOPIC AND MOLECULAR TECHNOLOGIES   (Romania)

^f Department of Research   (Romania)

Author keywords

Cancer stem cells; Drug delivery; Gold nanoparticles; Recurrent high grade gliomas; Temozolomide stability; Temozolomide therapy

Indexed keywords

ASPARTIC ACID; GOLD NANOPARTICLE; TEMOZOLOMIDE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL DESTRUCTION; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CANCER STEM CELL; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; FLOW CYTOMETRY; GLIOBLASTOMA; IN VITRO STUDY; INFRARED SPECTROSCOPY; INOPERABLE CANCER; RECURRENT CANCER; ULTRAVIOLET SPECTROSCOPY; X RAY PHOTOELECTRON SPECTROSCOPY;

CANCER STEM CELLS; DRUG DELIVERY; GOLD NANOPARTICLES; RECURRENT HIGH-GRADE GLIOMAS; TEMOZOLOMIDE STABILITY; TEMOZOLOMIDE THERAPY;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; ASPARTIC ACID; CELL SURVIVAL; CELLS, CULTURED; DACARBAZINE; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, NEOPLASM; DRUG STABILITY; DRUG SYNERGISM; FLOW CYTOMETRY; GLIOBLASTOMA; GOLD; HUMANS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; NEOPLASTIC STEM CELLS;

EID: 84874869964     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S37481     Document Type: Article

References (46)

1. Shapiro WR, Shapiro JR. Biology and treatment of malignant glioma. Oncology. 1998;12:233-240.
2. Henke G, Paulsen F, Steinbach JP, et al. Hypofractionated reirradiation for recurrent malignant glioma. Strahlenther Onkol. 2009;185:113-119. German.
3. Buie LW, Valgus JM. Current treatment options for the management of glioblastoma multiforme. Hematol Oncol Pharm. 2012;2:57-63.
4. Eyler CE, Rich JN. Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol. 2008;26:2839-2845.
5. Li X, Lewis MT, Huang J, et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst. 2008;100:672-679.
6. Diehn M, Cho RW, Lobo NA, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009;458: 780-783.
7. De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJ, Geertsma RE. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials. 2008;29:1912-1919.
8. Sonavane G, Tomoda K, Makino K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B Biointerfaces. 2008;66:274-280.
9. Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine (Lond). 2007;2:681-693.
10. Kim BYS, Rutka JT, Chan WCW. Nanomedicine. N Engl J Med. 2010;363:2434-2443.
11. Lammers T, Subr V, Ulbrich K, et al. HPMA-based polymer therapeutics improve the efficacy of surgery, of radiotherapy and of chemotherapy combinations. Nanomedicine (Lond). 2010;5:1501-1523.
12. Grimm J, Scheinberg DA. Will nanotechnology influence targeted cancer therapy? Semin Radiat Oncol. 2011;21:80-87.
13. Dharap SS, Wang Y, Chandna P, et al. Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. Proc Natl Acad Sci U S A. 2005;102:12962-12967.
14. Han G, Ghosh P, Rotello VM. Functionalized gold nanoparticles for drug delivery. Nanomedicine. 2007;2:113-123.
15. Liong M, Lu J, Kovochich M, et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano. 2008;2: 889-896.
16. Khan JA, Kudgus RA, Szabolcs A, et al. Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo. PLoS One. 2011;6:e20347.
17. Chen YH, Tsai CY, Huang PY, et al. Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. Mol Pharm. 2007;4:713-722.
18. Patra CR, Bhattacharya R, Wang E, et al. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res. 2008;68:1970-1978.
19. Liu C-J. Enhanced x-ray irradiation-induced cancer cell damage by gold nanoparticles treated by a new synthesis method of polyethylene glycol modification. Nanotechnology. 2008;19:295104.
20. Tomuleasa C, Soritau O, Rus-Ciuca D, et al. Functional and molecular characterization of glioblastoma multiforme derived cancer stem cells. J BUON. 2010;15:583-591.
21. Torcuator RG, Thind R, Patel M, et al. The role of salvage reirradiation for malignant gliomas that progress on bevacizumab. Neurooncol. 2010;97(3):401-407.
22. Stupp R, Mason WP, van den Bent MJ, et al. European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987-996.
23. Kora AJ, Beedu SR, Jayaraman A. Size-controlled green synthesis of silver nanoparticles mediated by gum ghatti (Anogeissus latifolia) and its biological activity. Org Med Chem Lett. 2012;2:17.
24. Iwasaki H, Suda T. Cancer stem cells and their niche. Cancer Sci. 2009;100:1166-1172.
25. Leiro J, Minni E, Suoninen E. Study of plasmon structure in XPS spectra of silver and gold. J Phys F Met Phys. 1983;13:215-221.
26. Kang ET, Neoh KG, Tan KL. X-ray photoelectron spectroscopic studies of electroactive polymers advances. Polymer Science. 1993;106: 135-190.
27. Cumpson PJ, Seah MP. Elastic scattering corrections in AES and XPS. II. Estimating attenuation lengths and conditions required for their valid use in overlayer/substrate experiments. Surf Interface Anal. 1997;25:430-446.
28. Dittmar T, Nagler C, Schwitalla S, Reith G, Niggemann B, Zänker KS. Recurrence cancer stem cells-made by cell fusion? Med Hypotheses. 2009;73:542-547.
29. Fabian A, Barok M, Vereb G, Szollosi J. Die hard: are cancer stem cells the Bruce Willises of tumor biology? Cytometry A. 2009;75A: 67-74.
30. Keysar SB, Jimeno A. More than markers: biological significance of cancer stem cell-defining molecules. Mol Cancer Ther. 2010;9: 92450-92457.
31. Butterworth K, McMahon S, Currell F, Prise M. Physical basis and biological mechanisms of gold nanoparticle radiosensitization. Nanoscale. 2012;4:4830-4838.
32. Orza A, Soritau O, Olenic L, et al. Electrically conductive gold-coated collagen nanofibers for placental-derived mesenchymal stem cells enhanced differentiation and proliferation. ACS Nano. 2011;5: 4490-4500.
33. Sathuluri RR, Yoshikawa H, Shimizu E, Saito M, Tamiya E. Gold nanoparticle-based surface-enhanced Raman scattering for noninvasive molecular probing of embryonic stem cell differentiation. PLoS One. 2011;6:e22802.
34. Ricles LM, Nam SY, Sokolov K, Emelianov SY, Suggs LJ. Function of mesenchymal stem cells following loading of gold nanotracers. Int J Nanomedicine. 2011;6:407-416.
35. Wang Y, Wang Y, Wang L, Che Y, Li Z, Kong D. Preparation and evaluation of magnetic nanoparticles for cell labeling. J Nanosci Nanotechnol. 2011;11:3749-3756.
36. Nativo P, Prior IA, Brust M. Uptake and intracellular fate of surface-modified gold nanoparticles. ACS Nano. 2008;2:1639-1644.
37. Maurer-Jones MA, Bantz KC, Love SA, Marquis BJ, Haynes CL. Toxicity of therapeutic nanoparticles. Nanomedicine. 2009;4:219-241.
38. Zhang Y, Xu Y, Li Z, et al. Mechanistic toxicity evaluation of pristine and PEGylated single-walled carbon nanotubes in neuronal PC12 cells. ACS Nano. 2011;5:7020-7033.
39. Florian IS, Tomuleasa C, Soritau O, et al. Cancer stem cells and malignant gliomas. From pathophysiology to targeted molecular therapy. J BUON. 2011;16:16-23.
40. Frosina G. DNA repair and resistance of gliomas to chemotherapy and radiotherapy. Mol Cancer Res. 2009;7:989-999.
41. Baguley BC. Multidrug resistance in cancer. Methods Mol Biol. 2010;596:1-14.
42. Huang X, Kang B, Qian W, et al. Comparative study of photothermolysis of cancer cells with nuclear-targeted or cytoplasm-targeted gold nanospheres: continuous wave or pulsed lasers. J Biomed Opt. 2010;15: 058002.
43. Zharov VP, Galitovsky V, Viegas, M. Photothermal detection of local thermal effects during selective nanophotothermolysis. Appl Phys Lett. 2003;83:4897-4899.
44. Kruse DE, Stephens DN, Lindfors HA, Ingham ES, Paoli EE, Ferrara KW. A radio-frequency coupling network for heating of citrate-coated gold nanoparticles for cancer therapy: design and analysis. IEEE Trans Biomed Eng. 2011;58:2002-2012.
45. Maksimova IL, Akchurin GG, Khlebtsov BN, et al. Near-infrared laser photothermal therapy of cancer by using gold nanoparticles: computer simulations and experiment. Med Laser Appl. 2007;22:199-206.
46. Porter MD, Bright TB, Allara DL, Chidsey CE. Spontaneously organized molecular assemblies. 4. Structural characterization of N-alkyl thiol monolayers on gold by optical ellipsometry, infrared spectroscopy, and electrochemistry. J Am Chem Soc. 1987;109:3559-3568.